Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Knop

Showing results (161-170 of 509) with videos related to

Pageof 51
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|May 14, 2013
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjectsF K Knop, E Konings, S Timmers, et al.
Scandinavian Journal of Gastroenterology|November 20, 2018
Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugsJens F Rehfeld, Filip K Knop, Ali Asmar, et al.
Kidney International|January 2, 2014
The authors replyThomas Idorn, Filip K Knop, Morten Jørgensen, et al.
Clinical and Translational Gastroenterology|January 14, 2025
Treatment of Bile Acid Diarrhea With Glucagon-Like Peptide 1 Receptor Agonists: A Promising Yet Understudied ApproachAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
Diabetes, Obesity & Metabolism|August 8, 2023
The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatideLaerke S Gasbjerg, Mette M Rosenkilde, Juris J Meier, et al.
The American Journal of Gastroenterology|May 8, 2024
Bile Acid Diarrhea Is Associated With an Increased Incidence of Gastrointestinal CancersAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Impaired regulation of the incretin effect in patients with type 2 diabetesJonatan I Bagger, Filip K Knop, Asger Lund, et al.
The American Journal of Gastroenterology|December 10, 2024
Response to Borup et alAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
Clinical and Translational Gastroenterology|May 23, 2025
Bile Acid Diarrhea Is Associated With an Increased Risk of Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort StudyAnne-Marie Ellegaard, Matilde Winther-Jensen, Line L Kårhus, et al.
Biomarkers in Medicine|September 10, 2016
The biology of glucagon and the consequences of hyperglucagonemiaNicolai J Wewer Albrechtsen, Rune E Kuhre, Jens Pedersen, et al.
Pageof 51

Showing results (161-170 of 509) with videos related to

Sort By:
Pageof 51
Diabetic Medicine : a Journal of the British Diabetic Association|May 14, 2013
Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjectsF K Knop, E Konings, S Timmers, et al.
Scandinavian Journal of Gastroenterology|November 20, 2018
Cholecystokinin secretion is suppressed by glucagon-like peptide-1: clue to the mechanism of the adverse gallbladder events of GLP-1-derived drugsJens F Rehfeld, Filip K Knop, Ali Asmar, et al.
Kidney International|January 2, 2014
The authors replyThomas Idorn, Filip K Knop, Morten Jørgensen, et al.
Clinical and Translational Gastroenterology|January 14, 2025
Treatment of Bile Acid Diarrhea With Glucagon-Like Peptide 1 Receptor Agonists: A Promising Yet Understudied ApproachAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
Diabetes, Obesity & Metabolism|August 8, 2023
The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatideLaerke S Gasbjerg, Mette M Rosenkilde, Juris J Meier, et al.
The American Journal of Gastroenterology|May 8, 2024
Bile Acid Diarrhea Is Associated With an Increased Incidence of Gastrointestinal CancersAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 22, 2011
Impaired regulation of the incretin effect in patients with type 2 diabetesJonatan I Bagger, Filip K Knop, Asger Lund, et al.
The American Journal of Gastroenterology|December 10, 2024
Response to Borup et alAnne-Marie Ellegaard, Martin L Kårhus, Matilde Winther-Jensen, et al.
Clinical and Translational Gastroenterology|May 23, 2025
Bile Acid Diarrhea Is Associated With an Increased Risk of Type 2 Diabetes and Cardiovascular Disease: A Nationwide Cohort StudyAnne-Marie Ellegaard, Matilde Winther-Jensen, Line L Kårhus, et al.
Biomarkers in Medicine|September 10, 2016
The biology of glucagon and the consequences of hyperglucagonemiaNicolai J Wewer Albrechtsen, Rune E Kuhre, Jens Pedersen, et al.
Pageof 51